Global Aminoglycoside Drug Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
Aminoglycosides are a class of antibiotics used mainly in the treatment of aerobic gram-negative bacilli infections, although they are also effective against other bacteria including Staphylococci and Mycobacterium tuberculosis. They are often used in combination with other antibiotics.
According to our (Global Info Research) latest study, the global Aminoglycoside Drug market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Aminoglycoside Drug market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Aminoglycoside Drug market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2018-2029
Global Aminoglycoside Drug market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2018-2029
Global Aminoglycoside Drug market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2018-2029
Global Aminoglycoside Drug market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Aminoglycoside Drug
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Aminoglycoside Drug market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Jemicare, Teva, Novartis Pharmaceuticals, Fangyuan-pharma and Aike Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Aminoglycoside Drug market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Aminoglycoside Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Aminoglycoside Drug, with price, sales, revenue and global market share of Aminoglycoside Drug from 2018 to 2023.
Chapter 3, the Aminoglycoside Drug competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Aminoglycoside Drug breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Aminoglycoside Drug market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Aminoglycoside Drug.
Chapter 14 and 15, to describe Aminoglycoside Drug sales channel, distributors, customers, research findings and conclusion.
According to our (Global Info Research) latest study, the global Aminoglycoside Drug market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Aminoglycoside Drug market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Aminoglycoside Drug market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2018-2029
Global Aminoglycoside Drug market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2018-2029
Global Aminoglycoside Drug market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2018-2029
Global Aminoglycoside Drug market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Aminoglycoside Drug
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Aminoglycoside Drug market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Jemicare, Teva, Novartis Pharmaceuticals, Fangyuan-pharma and Aike Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Aminoglycoside Drug market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Neomycin
- Tobramycin
- Gentamicin
- Amikacin
- Etimicin
- Others
- Hospital
- Retail Pharmacy
- Others
- Jemicare
- Teva
- Novartis Pharmaceuticals
- Fangyuan-pharma
- Aike Pharmaceutical
- Cipla
- Pfizer
- FRESENIUS KABI
- Sun Pharma
- Hikma
- Lannett Company
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Aminoglycoside Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Aminoglycoside Drug, with price, sales, revenue and global market share of Aminoglycoside Drug from 2018 to 2023.
Chapter 3, the Aminoglycoside Drug competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Aminoglycoside Drug breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Aminoglycoside Drug market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Aminoglycoside Drug.
Chapter 14 and 15, to describe Aminoglycoside Drug sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Aminoglycoside Drug
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Aminoglycoside Drug Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Neomycin
1.3.3 Tobramycin
1.3.4 Gentamicin
1.3.5 Amikacin
1.3.6 Etimicin
1.3.7 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Aminoglycoside Drug Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Retail Pharmacy
1.4.4 Others
1.5 Global Aminoglycoside Drug Market Size & Forecast
1.5.1 Global Aminoglycoside Drug Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Aminoglycoside Drug Sales Quantity (2018-2029)
1.5.3 Global Aminoglycoside Drug Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Jemicare
2.1.1 Jemicare Details
2.1.2 Jemicare Major Business
2.1.3 Jemicare Aminoglycoside Drug Product and Services
2.1.4 Jemicare Aminoglycoside Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Jemicare Recent Developments/Updates
2.2 Teva
2.2.1 Teva Details
2.2.2 Teva Major Business
2.2.3 Teva Aminoglycoside Drug Product and Services
2.2.4 Teva Aminoglycoside Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Teva Recent Developments/Updates
2.3 Novartis Pharmaceuticals
2.3.1 Novartis Pharmaceuticals Details
2.3.2 Novartis Pharmaceuticals Major Business
2.3.3 Novartis Pharmaceuticals Aminoglycoside Drug Product and Services
2.3.4 Novartis Pharmaceuticals Aminoglycoside Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Novartis Pharmaceuticals Recent Developments/Updates
2.4 Fangyuan-pharma
2.4.1 Fangyuan-pharma Details
2.4.2 Fangyuan-pharma Major Business
2.4.3 Fangyuan-pharma Aminoglycoside Drug Product and Services
2.4.4 Fangyuan-pharma Aminoglycoside Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Fangyuan-pharma Recent Developments/Updates
2.5 Aike Pharmaceutical
2.5.1 Aike Pharmaceutical Details
2.5.2 Aike Pharmaceutical Major Business
2.5.3 Aike Pharmaceutical Aminoglycoside Drug Product and Services
2.5.4 Aike Pharmaceutical Aminoglycoside Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Aike Pharmaceutical Recent Developments/Updates
2.6 Cipla
2.6.1 Cipla Details
2.6.2 Cipla Major Business
2.6.3 Cipla Aminoglycoside Drug Product and Services
2.6.4 Cipla Aminoglycoside Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Cipla Recent Developments/Updates
2.7 Pfizer
2.7.1 Pfizer Details
2.7.2 Pfizer Major Business
2.7.3 Pfizer Aminoglycoside Drug Product and Services
2.7.4 Pfizer Aminoglycoside Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Pfizer Recent Developments/Updates
2.8 FRESENIUS KABI
2.8.1 FRESENIUS KABI Details
2.8.2 FRESENIUS KABI Major Business
2.8.3 FRESENIUS KABI Aminoglycoside Drug Product and Services
2.8.4 FRESENIUS KABI Aminoglycoside Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 FRESENIUS KABI Recent Developments/Updates
2.9 Sun Pharma
2.9.1 Sun Pharma Details
2.9.2 Sun Pharma Major Business
2.9.3 Sun Pharma Aminoglycoside Drug Product and Services
2.9.4 Sun Pharma Aminoglycoside Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Sun Pharma Recent Developments/Updates
2.10 Hikma
2.10.1 Hikma Details
2.10.2 Hikma Major Business
2.10.3 Hikma Aminoglycoside Drug Product and Services
2.10.4 Hikma Aminoglycoside Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Hikma Recent Developments/Updates
2.11 Lannett Company
2.11.1 Lannett Company Details
2.11.2 Lannett Company Major Business
2.11.3 Lannett Company Aminoglycoside Drug Product and Services
2.11.4 Lannett Company Aminoglycoside Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Lannett Company Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: AMINOGLYCOSIDE DRUG BY MANUFACTURER
3.1 Global Aminoglycoside Drug Sales Quantity by Manufacturer (2018-2023)
3.2 Global Aminoglycoside Drug Revenue by Manufacturer (2018-2023)
3.3 Global Aminoglycoside Drug Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Aminoglycoside Drug by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Aminoglycoside Drug Manufacturer Market Share in 2022
3.4.2 Top 6 Aminoglycoside Drug Manufacturer Market Share in 2022
3.5 Aminoglycoside Drug Market: Overall Company Footprint Analysis
3.5.1 Aminoglycoside Drug Market: Region Footprint
3.5.2 Aminoglycoside Drug Market: Company Product Type Footprint
3.5.3 Aminoglycoside Drug Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Aminoglycoside Drug Market Size by Region
4.1.1 Global Aminoglycoside Drug Sales Quantity by Region (2018-2029)
4.1.2 Global Aminoglycoside Drug Consumption Value by Region (2018-2029)
4.1.3 Global Aminoglycoside Drug Average Price by Region (2018-2029)
4.2 North America Aminoglycoside Drug Consumption Value (2018-2029)
4.3 Europe Aminoglycoside Drug Consumption Value (2018-2029)
4.4 Asia-Pacific Aminoglycoside Drug Consumption Value (2018-2029)
4.5 South America Aminoglycoside Drug Consumption Value (2018-2029)
4.6 Middle East and Africa Aminoglycoside Drug Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Aminoglycoside Drug Sales Quantity by Type (2018-2029)
5.2 Global Aminoglycoside Drug Consumption Value by Type (2018-2029)
5.3 Global Aminoglycoside Drug Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Aminoglycoside Drug Sales Quantity by Application (2018-2029)
6.2 Global Aminoglycoside Drug Consumption Value by Application (2018-2029)
6.3 Global Aminoglycoside Drug Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Aminoglycoside Drug Sales Quantity by Type (2018-2029)
7.2 North America Aminoglycoside Drug Sales Quantity by Application (2018-2029)
7.3 North America Aminoglycoside Drug Market Size by Country
7.3.1 North America Aminoglycoside Drug Sales Quantity by Country (2018-2029)
7.3.2 North America Aminoglycoside Drug Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Aminoglycoside Drug Sales Quantity by Type (2018-2029)
8.2 Europe Aminoglycoside Drug Sales Quantity by Application (2018-2029)
8.3 Europe Aminoglycoside Drug Market Size by Country
8.3.1 Europe Aminoglycoside Drug Sales Quantity by Country (2018-2029)
8.3.2 Europe Aminoglycoside Drug Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Aminoglycoside Drug Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Aminoglycoside Drug Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Aminoglycoside Drug Market Size by Region
9.3.1 Asia-Pacific Aminoglycoside Drug Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Aminoglycoside Drug Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Aminoglycoside Drug Sales Quantity by Type (2018-2029)
10.2 South America Aminoglycoside Drug Sales Quantity by Application (2018-2029)
10.3 South America Aminoglycoside Drug Market Size by Country
10.3.1 South America Aminoglycoside Drug Sales Quantity by Country (2018-2029)
10.3.2 South America Aminoglycoside Drug Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Aminoglycoside Drug Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Aminoglycoside Drug Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Aminoglycoside Drug Market Size by Country
11.3.1 Middle East & Africa Aminoglycoside Drug Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Aminoglycoside Drug Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Aminoglycoside Drug Market Drivers
12.2 Aminoglycoside Drug Market Restraints
12.3 Aminoglycoside Drug Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Aminoglycoside Drug and Key Manufacturers
13.2 Manufacturing Costs Percentage of Aminoglycoside Drug
13.3 Aminoglycoside Drug Production Process
13.4 Aminoglycoside Drug Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Aminoglycoside Drug Typical Distributors
14.3 Aminoglycoside Drug Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Aminoglycoside Drug
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Aminoglycoside Drug Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Neomycin
1.3.3 Tobramycin
1.3.4 Gentamicin
1.3.5 Amikacin
1.3.6 Etimicin
1.3.7 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Aminoglycoside Drug Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Retail Pharmacy
1.4.4 Others
1.5 Global Aminoglycoside Drug Market Size & Forecast
1.5.1 Global Aminoglycoside Drug Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Aminoglycoside Drug Sales Quantity (2018-2029)
1.5.3 Global Aminoglycoside Drug Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Jemicare
2.1.1 Jemicare Details
2.1.2 Jemicare Major Business
2.1.3 Jemicare Aminoglycoside Drug Product and Services
2.1.4 Jemicare Aminoglycoside Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Jemicare Recent Developments/Updates
2.2 Teva
2.2.1 Teva Details
2.2.2 Teva Major Business
2.2.3 Teva Aminoglycoside Drug Product and Services
2.2.4 Teva Aminoglycoside Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Teva Recent Developments/Updates
2.3 Novartis Pharmaceuticals
2.3.1 Novartis Pharmaceuticals Details
2.3.2 Novartis Pharmaceuticals Major Business
2.3.3 Novartis Pharmaceuticals Aminoglycoside Drug Product and Services
2.3.4 Novartis Pharmaceuticals Aminoglycoside Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Novartis Pharmaceuticals Recent Developments/Updates
2.4 Fangyuan-pharma
2.4.1 Fangyuan-pharma Details
2.4.2 Fangyuan-pharma Major Business
2.4.3 Fangyuan-pharma Aminoglycoside Drug Product and Services
2.4.4 Fangyuan-pharma Aminoglycoside Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Fangyuan-pharma Recent Developments/Updates
2.5 Aike Pharmaceutical
2.5.1 Aike Pharmaceutical Details
2.5.2 Aike Pharmaceutical Major Business
2.5.3 Aike Pharmaceutical Aminoglycoside Drug Product and Services
2.5.4 Aike Pharmaceutical Aminoglycoside Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Aike Pharmaceutical Recent Developments/Updates
2.6 Cipla
2.6.1 Cipla Details
2.6.2 Cipla Major Business
2.6.3 Cipla Aminoglycoside Drug Product and Services
2.6.4 Cipla Aminoglycoside Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Cipla Recent Developments/Updates
2.7 Pfizer
2.7.1 Pfizer Details
2.7.2 Pfizer Major Business
2.7.3 Pfizer Aminoglycoside Drug Product and Services
2.7.4 Pfizer Aminoglycoside Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Pfizer Recent Developments/Updates
2.8 FRESENIUS KABI
2.8.1 FRESENIUS KABI Details
2.8.2 FRESENIUS KABI Major Business
2.8.3 FRESENIUS KABI Aminoglycoside Drug Product and Services
2.8.4 FRESENIUS KABI Aminoglycoside Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 FRESENIUS KABI Recent Developments/Updates
2.9 Sun Pharma
2.9.1 Sun Pharma Details
2.9.2 Sun Pharma Major Business
2.9.3 Sun Pharma Aminoglycoside Drug Product and Services
2.9.4 Sun Pharma Aminoglycoside Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Sun Pharma Recent Developments/Updates
2.10 Hikma
2.10.1 Hikma Details
2.10.2 Hikma Major Business
2.10.3 Hikma Aminoglycoside Drug Product and Services
2.10.4 Hikma Aminoglycoside Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Hikma Recent Developments/Updates
2.11 Lannett Company
2.11.1 Lannett Company Details
2.11.2 Lannett Company Major Business
2.11.3 Lannett Company Aminoglycoside Drug Product and Services
2.11.4 Lannett Company Aminoglycoside Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Lannett Company Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: AMINOGLYCOSIDE DRUG BY MANUFACTURER
3.1 Global Aminoglycoside Drug Sales Quantity by Manufacturer (2018-2023)
3.2 Global Aminoglycoside Drug Revenue by Manufacturer (2018-2023)
3.3 Global Aminoglycoside Drug Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Aminoglycoside Drug by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Aminoglycoside Drug Manufacturer Market Share in 2022
3.4.2 Top 6 Aminoglycoside Drug Manufacturer Market Share in 2022
3.5 Aminoglycoside Drug Market: Overall Company Footprint Analysis
3.5.1 Aminoglycoside Drug Market: Region Footprint
3.5.2 Aminoglycoside Drug Market: Company Product Type Footprint
3.5.3 Aminoglycoside Drug Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Aminoglycoside Drug Market Size by Region
4.1.1 Global Aminoglycoside Drug Sales Quantity by Region (2018-2029)
4.1.2 Global Aminoglycoside Drug Consumption Value by Region (2018-2029)
4.1.3 Global Aminoglycoside Drug Average Price by Region (2018-2029)
4.2 North America Aminoglycoside Drug Consumption Value (2018-2029)
4.3 Europe Aminoglycoside Drug Consumption Value (2018-2029)
4.4 Asia-Pacific Aminoglycoside Drug Consumption Value (2018-2029)
4.5 South America Aminoglycoside Drug Consumption Value (2018-2029)
4.6 Middle East and Africa Aminoglycoside Drug Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Aminoglycoside Drug Sales Quantity by Type (2018-2029)
5.2 Global Aminoglycoside Drug Consumption Value by Type (2018-2029)
5.3 Global Aminoglycoside Drug Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Aminoglycoside Drug Sales Quantity by Application (2018-2029)
6.2 Global Aminoglycoside Drug Consumption Value by Application (2018-2029)
6.3 Global Aminoglycoside Drug Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Aminoglycoside Drug Sales Quantity by Type (2018-2029)
7.2 North America Aminoglycoside Drug Sales Quantity by Application (2018-2029)
7.3 North America Aminoglycoside Drug Market Size by Country
7.3.1 North America Aminoglycoside Drug Sales Quantity by Country (2018-2029)
7.3.2 North America Aminoglycoside Drug Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Aminoglycoside Drug Sales Quantity by Type (2018-2029)
8.2 Europe Aminoglycoside Drug Sales Quantity by Application (2018-2029)
8.3 Europe Aminoglycoside Drug Market Size by Country
8.3.1 Europe Aminoglycoside Drug Sales Quantity by Country (2018-2029)
8.3.2 Europe Aminoglycoside Drug Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Aminoglycoside Drug Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Aminoglycoside Drug Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Aminoglycoside Drug Market Size by Region
9.3.1 Asia-Pacific Aminoglycoside Drug Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Aminoglycoside Drug Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Aminoglycoside Drug Sales Quantity by Type (2018-2029)
10.2 South America Aminoglycoside Drug Sales Quantity by Application (2018-2029)
10.3 South America Aminoglycoside Drug Market Size by Country
10.3.1 South America Aminoglycoside Drug Sales Quantity by Country (2018-2029)
10.3.2 South America Aminoglycoside Drug Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Aminoglycoside Drug Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Aminoglycoside Drug Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Aminoglycoside Drug Market Size by Country
11.3.1 Middle East & Africa Aminoglycoside Drug Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Aminoglycoside Drug Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Aminoglycoside Drug Market Drivers
12.2 Aminoglycoside Drug Market Restraints
12.3 Aminoglycoside Drug Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Aminoglycoside Drug and Key Manufacturers
13.2 Manufacturing Costs Percentage of Aminoglycoside Drug
13.3 Aminoglycoside Drug Production Process
13.4 Aminoglycoside Drug Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Aminoglycoside Drug Typical Distributors
14.3 Aminoglycoside Drug Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Aminoglycoside Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Aminoglycoside Drug Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Jemicare Basic Information, Manufacturing Base and Competitors
Table 4. Jemicare Major Business
Table 5. Jemicare Aminoglycoside Drug Product and Services
Table 6. Jemicare Aminoglycoside Drug Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Jemicare Recent Developments/Updates
Table 8. Teva Basic Information, Manufacturing Base and Competitors
Table 9. Teva Major Business
Table 10. Teva Aminoglycoside Drug Product and Services
Table 11. Teva Aminoglycoside Drug Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Teva Recent Developments/Updates
Table 13. Novartis Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 14. Novartis Pharmaceuticals Major Business
Table 15. Novartis Pharmaceuticals Aminoglycoside Drug Product and Services
Table 16. Novartis Pharmaceuticals Aminoglycoside Drug Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Novartis Pharmaceuticals Recent Developments/Updates
Table 18. Fangyuan-pharma Basic Information, Manufacturing Base and Competitors
Table 19. Fangyuan-pharma Major Business
Table 20. Fangyuan-pharma Aminoglycoside Drug Product and Services
Table 21. Fangyuan-pharma Aminoglycoside Drug Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Fangyuan-pharma Recent Developments/Updates
Table 23. Aike Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 24. Aike Pharmaceutical Major Business
Table 25. Aike Pharmaceutical Aminoglycoside Drug Product and Services
Table 26. Aike Pharmaceutical Aminoglycoside Drug Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Aike Pharmaceutical Recent Developments/Updates
Table 28. Cipla Basic Information, Manufacturing Base and Competitors
Table 29. Cipla Major Business
Table 30. Cipla Aminoglycoside Drug Product and Services
Table 31. Cipla Aminoglycoside Drug Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Cipla Recent Developments/Updates
Table 33. Pfizer Basic Information, Manufacturing Base and Competitors
Table 34. Pfizer Major Business
Table 35. Pfizer Aminoglycoside Drug Product and Services
Table 36. Pfizer Aminoglycoside Drug Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Pfizer Recent Developments/Updates
Table 38. FRESENIUS KABI Basic Information, Manufacturing Base and Competitors
Table 39. FRESENIUS KABI Major Business
Table 40. FRESENIUS KABI Aminoglycoside Drug Product and Services
Table 41. FRESENIUS KABI Aminoglycoside Drug Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. FRESENIUS KABI Recent Developments/Updates
Table 43. Sun Pharma Basic Information, Manufacturing Base and Competitors
Table 44. Sun Pharma Major Business
Table 45. Sun Pharma Aminoglycoside Drug Product and Services
Table 46. Sun Pharma Aminoglycoside Drug Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Sun Pharma Recent Developments/Updates
Table 48. Hikma Basic Information, Manufacturing Base and Competitors
Table 49. Hikma Major Business
Table 50. Hikma Aminoglycoside Drug Product and Services
Table 51. Hikma Aminoglycoside Drug Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Hikma Recent Developments/Updates
Table 53. Lannett Company Basic Information, Manufacturing Base and Competitors
Table 54. Lannett Company Major Business
Table 55. Lannett Company Aminoglycoside Drug Product and Services
Table 56. Lannett Company Aminoglycoside Drug Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Lannett Company Recent Developments/Updates
Table 58. Global Aminoglycoside Drug Sales Quantity by Manufacturer (2018-2023) & (Units)
Table 59. Global Aminoglycoside Drug Revenue by Manufacturer (2018-2023) & (USD Million)
Table 60. Global Aminoglycoside Drug Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 61. Market Position of Manufacturers in Aminoglycoside Drug, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 62. Head Office and Aminoglycoside Drug Production Site of Key Manufacturer
Table 63. Aminoglycoside Drug Market: Company Product Type Footprint
Table 64. Aminoglycoside Drug Market: Company Product Application Footprint
Table 65. Aminoglycoside Drug New Market Entrants and Barriers to Market Entry
Table 66. Aminoglycoside Drug Mergers, Acquisition, Agreements, and Collaborations
Table 67. Global Aminoglycoside Drug Sales Quantity by Region (2018-2023) & (Units)
Table 68. Global Aminoglycoside Drug Sales Quantity by Region (2024-2029) & (Units)
Table 69. Global Aminoglycoside Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 70. Global Aminoglycoside Drug Consumption Value by Region (2024-2029) & (USD Million)
Table 71. Global Aminoglycoside Drug Average Price by Region (2018-2023) & (US$/Unit)
Table 72. Global Aminoglycoside Drug Average Price by Region (2024-2029) & (US$/Unit)
Table 73. Global Aminoglycoside Drug Sales Quantity by Type (2018-2023) & (Units)
Table 74. Global Aminoglycoside Drug Sales Quantity by Type (2024-2029) & (Units)
Table 75. Global Aminoglycoside Drug Consumption Value by Type (2018-2023) & (USD Million)
Table 76. Global Aminoglycoside Drug Consumption Value by Type (2024-2029) & (USD Million)
Table 77. Global Aminoglycoside Drug Average Price by Type (2018-2023) & (US$/Unit)
Table 78. Global Aminoglycoside Drug Average Price by Type (2024-2029) & (US$/Unit)
Table 79. Global Aminoglycoside Drug Sales Quantity by Application (2018-2023) & (Units)
Table 80. Global Aminoglycoside Drug Sales Quantity by Application (2024-2029) & (Units)
Table 81. Global Aminoglycoside Drug Consumption Value by Application (2018-2023) & (USD Million)
Table 82. Global Aminoglycoside Drug Consumption Value by Application (2024-2029) & (USD Million)
Table 83. Global Aminoglycoside Drug Average Price by Application (2018-2023) & (US$/Unit)
Table 84. Global Aminoglycoside Drug Average Price by Application (2024-2029) & (US$/Unit)
Table 85. North America Aminoglycoside Drug Sales Quantity by Type (2018-2023) & (Units)
Table 86. North America Aminoglycoside Drug Sales Quantity by Type (2024-2029) & (Units)
Table 87. North America Aminoglycoside Drug Sales Quantity by Application (2018-2023) & (Units)
Table 88. North America Aminoglycoside Drug Sales Quantity by Application (2024-2029) & (Units)
Table 89. North America Aminoglycoside Drug Sales Quantity by Country (2018-2023) & (Units)
Table 90. North America Aminoglycoside Drug Sales Quantity by Country (2024-2029) & (Units)
Table 91. North America Aminoglycoside Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 92. North America Aminoglycoside Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 93. Europe Aminoglycoside Drug Sales Quantity by Type (2018-2023) & (Units)
Table 94. Europe Aminoglycoside Drug Sales Quantity by Type (2024-2029) & (Units)
Table 95. Europe Aminoglycoside Drug Sales Quantity by Application (2018-2023) & (Units)
Table 96. Europe Aminoglycoside Drug Sales Quantity by Application (2024-2029) & (Units)
Table 97. Europe Aminoglycoside Drug Sales Quantity by Country (2018-2023) & (Units)
Table 98. Europe Aminoglycoside Drug Sales Quantity by Country (2024-2029) & (Units)
Table 99. Europe Aminoglycoside Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 100. Europe Aminoglycoside Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 101. Asia-Pacific Aminoglycoside Drug Sales Quantity by Type (2018-2023) & (Units)
Table 102. Asia-Pacific Aminoglycoside Drug Sales Quantity by Type (2024-2029) & (Units)
Table 103. Asia-Pacific Aminoglycoside Drug Sales Quantity by Application (2018-2023) & (Units)
Table 104. Asia-Pacific Aminoglycoside Drug Sales Quantity by Application (2024-2029) & (Units)
Table 105. Asia-Pacific Aminoglycoside Drug Sales Quantity by Region (2018-2023) & (Units)
Table 106. Asia-Pacific Aminoglycoside Drug Sales Quantity by Region (2024-2029) & (Units)
Table 107. Asia-Pacific Aminoglycoside Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 108. Asia-Pacific Aminoglycoside Drug Consumption Value by Region (2024-2029) & (USD Million)
Table 109. South America Aminoglycoside Drug Sales Quantity by Type (2018-2023) & (Units)
Table 110. South America Aminoglycoside Drug Sales Quantity by Type (2024-2029) & (Units)
Table 111. South America Aminoglycoside Drug Sales Quantity by Application (2018-2023) & (Units)
Table 112. South America Aminoglycoside Drug Sales Quantity by Application (2024-2029) & (Units)
Table 113. South America Aminoglycoside Drug Sales Quantity by Country (2018-2023) & (Units)
Table 114. South America Aminoglycoside Drug Sales Quantity by Country (2024-2029) & (Units)
Table 115. South America Aminoglycoside Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 116. South America Aminoglycoside Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 117. Middle East & Africa Aminoglycoside Drug Sales Quantity by Type (2018-2023) & (Units)
Table 118. Middle East & Africa Aminoglycoside Drug Sales Quantity by Type (2024-2029) & (Units)
Table 119. Middle East & Africa Aminoglycoside Drug Sales Quantity by Application (2018-2023) & (Units)
Table 120. Middle East & Africa Aminoglycoside Drug Sales Quantity by Application (2024-2029) & (Units)
Table 121. Middle East & Africa Aminoglycoside Drug Sales Quantity by Region (2018-2023) & (Units)
Table 122. Middle East & Africa Aminoglycoside Drug Sales Quantity by Region (2024-2029) & (Units)
Table 123. Middle East & Africa Aminoglycoside Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 124. Middle East & Africa Aminoglycoside Drug Consumption Value by Region (2024-2029) & (USD Million)
Table 125. Aminoglycoside Drug Raw Material
Table 126. Key Manufacturers of Aminoglycoside Drug Raw Materials
Table 127. Aminoglycoside Drug Typical Distributors
Table 128. Aminoglycoside Drug Typical Customers
Table 1. Global Aminoglycoside Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Aminoglycoside Drug Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Jemicare Basic Information, Manufacturing Base and Competitors
Table 4. Jemicare Major Business
Table 5. Jemicare Aminoglycoside Drug Product and Services
Table 6. Jemicare Aminoglycoside Drug Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Jemicare Recent Developments/Updates
Table 8. Teva Basic Information, Manufacturing Base and Competitors
Table 9. Teva Major Business
Table 10. Teva Aminoglycoside Drug Product and Services
Table 11. Teva Aminoglycoside Drug Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Teva Recent Developments/Updates
Table 13. Novartis Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 14. Novartis Pharmaceuticals Major Business
Table 15. Novartis Pharmaceuticals Aminoglycoside Drug Product and Services
Table 16. Novartis Pharmaceuticals Aminoglycoside Drug Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Novartis Pharmaceuticals Recent Developments/Updates
Table 18. Fangyuan-pharma Basic Information, Manufacturing Base and Competitors
Table 19. Fangyuan-pharma Major Business
Table 20. Fangyuan-pharma Aminoglycoside Drug Product and Services
Table 21. Fangyuan-pharma Aminoglycoside Drug Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Fangyuan-pharma Recent Developments/Updates
Table 23. Aike Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 24. Aike Pharmaceutical Major Business
Table 25. Aike Pharmaceutical Aminoglycoside Drug Product and Services
Table 26. Aike Pharmaceutical Aminoglycoside Drug Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Aike Pharmaceutical Recent Developments/Updates
Table 28. Cipla Basic Information, Manufacturing Base and Competitors
Table 29. Cipla Major Business
Table 30. Cipla Aminoglycoside Drug Product and Services
Table 31. Cipla Aminoglycoside Drug Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Cipla Recent Developments/Updates
Table 33. Pfizer Basic Information, Manufacturing Base and Competitors
Table 34. Pfizer Major Business
Table 35. Pfizer Aminoglycoside Drug Product and Services
Table 36. Pfizer Aminoglycoside Drug Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Pfizer Recent Developments/Updates
Table 38. FRESENIUS KABI Basic Information, Manufacturing Base and Competitors
Table 39. FRESENIUS KABI Major Business
Table 40. FRESENIUS KABI Aminoglycoside Drug Product and Services
Table 41. FRESENIUS KABI Aminoglycoside Drug Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. FRESENIUS KABI Recent Developments/Updates
Table 43. Sun Pharma Basic Information, Manufacturing Base and Competitors
Table 44. Sun Pharma Major Business
Table 45. Sun Pharma Aminoglycoside Drug Product and Services
Table 46. Sun Pharma Aminoglycoside Drug Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Sun Pharma Recent Developments/Updates
Table 48. Hikma Basic Information, Manufacturing Base and Competitors
Table 49. Hikma Major Business
Table 50. Hikma Aminoglycoside Drug Product and Services
Table 51. Hikma Aminoglycoside Drug Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Hikma Recent Developments/Updates
Table 53. Lannett Company Basic Information, Manufacturing Base and Competitors
Table 54. Lannett Company Major Business
Table 55. Lannett Company Aminoglycoside Drug Product and Services
Table 56. Lannett Company Aminoglycoside Drug Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Lannett Company Recent Developments/Updates
Table 58. Global Aminoglycoside Drug Sales Quantity by Manufacturer (2018-2023) & (Units)
Table 59. Global Aminoglycoside Drug Revenue by Manufacturer (2018-2023) & (USD Million)
Table 60. Global Aminoglycoside Drug Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 61. Market Position of Manufacturers in Aminoglycoside Drug, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 62. Head Office and Aminoglycoside Drug Production Site of Key Manufacturer
Table 63. Aminoglycoside Drug Market: Company Product Type Footprint
Table 64. Aminoglycoside Drug Market: Company Product Application Footprint
Table 65. Aminoglycoside Drug New Market Entrants and Barriers to Market Entry
Table 66. Aminoglycoside Drug Mergers, Acquisition, Agreements, and Collaborations
Table 67. Global Aminoglycoside Drug Sales Quantity by Region (2018-2023) & (Units)
Table 68. Global Aminoglycoside Drug Sales Quantity by Region (2024-2029) & (Units)
Table 69. Global Aminoglycoside Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 70. Global Aminoglycoside Drug Consumption Value by Region (2024-2029) & (USD Million)
Table 71. Global Aminoglycoside Drug Average Price by Region (2018-2023) & (US$/Unit)
Table 72. Global Aminoglycoside Drug Average Price by Region (2024-2029) & (US$/Unit)
Table 73. Global Aminoglycoside Drug Sales Quantity by Type (2018-2023) & (Units)
Table 74. Global Aminoglycoside Drug Sales Quantity by Type (2024-2029) & (Units)
Table 75. Global Aminoglycoside Drug Consumption Value by Type (2018-2023) & (USD Million)
Table 76. Global Aminoglycoside Drug Consumption Value by Type (2024-2029) & (USD Million)
Table 77. Global Aminoglycoside Drug Average Price by Type (2018-2023) & (US$/Unit)
Table 78. Global Aminoglycoside Drug Average Price by Type (2024-2029) & (US$/Unit)
Table 79. Global Aminoglycoside Drug Sales Quantity by Application (2018-2023) & (Units)
Table 80. Global Aminoglycoside Drug Sales Quantity by Application (2024-2029) & (Units)
Table 81. Global Aminoglycoside Drug Consumption Value by Application (2018-2023) & (USD Million)
Table 82. Global Aminoglycoside Drug Consumption Value by Application (2024-2029) & (USD Million)
Table 83. Global Aminoglycoside Drug Average Price by Application (2018-2023) & (US$/Unit)
Table 84. Global Aminoglycoside Drug Average Price by Application (2024-2029) & (US$/Unit)
Table 85. North America Aminoglycoside Drug Sales Quantity by Type (2018-2023) & (Units)
Table 86. North America Aminoglycoside Drug Sales Quantity by Type (2024-2029) & (Units)
Table 87. North America Aminoglycoside Drug Sales Quantity by Application (2018-2023) & (Units)
Table 88. North America Aminoglycoside Drug Sales Quantity by Application (2024-2029) & (Units)
Table 89. North America Aminoglycoside Drug Sales Quantity by Country (2018-2023) & (Units)
Table 90. North America Aminoglycoside Drug Sales Quantity by Country (2024-2029) & (Units)
Table 91. North America Aminoglycoside Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 92. North America Aminoglycoside Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 93. Europe Aminoglycoside Drug Sales Quantity by Type (2018-2023) & (Units)
Table 94. Europe Aminoglycoside Drug Sales Quantity by Type (2024-2029) & (Units)
Table 95. Europe Aminoglycoside Drug Sales Quantity by Application (2018-2023) & (Units)
Table 96. Europe Aminoglycoside Drug Sales Quantity by Application (2024-2029) & (Units)
Table 97. Europe Aminoglycoside Drug Sales Quantity by Country (2018-2023) & (Units)
Table 98. Europe Aminoglycoside Drug Sales Quantity by Country (2024-2029) & (Units)
Table 99. Europe Aminoglycoside Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 100. Europe Aminoglycoside Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 101. Asia-Pacific Aminoglycoside Drug Sales Quantity by Type (2018-2023) & (Units)
Table 102. Asia-Pacific Aminoglycoside Drug Sales Quantity by Type (2024-2029) & (Units)
Table 103. Asia-Pacific Aminoglycoside Drug Sales Quantity by Application (2018-2023) & (Units)
Table 104. Asia-Pacific Aminoglycoside Drug Sales Quantity by Application (2024-2029) & (Units)
Table 105. Asia-Pacific Aminoglycoside Drug Sales Quantity by Region (2018-2023) & (Units)
Table 106. Asia-Pacific Aminoglycoside Drug Sales Quantity by Region (2024-2029) & (Units)
Table 107. Asia-Pacific Aminoglycoside Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 108. Asia-Pacific Aminoglycoside Drug Consumption Value by Region (2024-2029) & (USD Million)
Table 109. South America Aminoglycoside Drug Sales Quantity by Type (2018-2023) & (Units)
Table 110. South America Aminoglycoside Drug Sales Quantity by Type (2024-2029) & (Units)
Table 111. South America Aminoglycoside Drug Sales Quantity by Application (2018-2023) & (Units)
Table 112. South America Aminoglycoside Drug Sales Quantity by Application (2024-2029) & (Units)
Table 113. South America Aminoglycoside Drug Sales Quantity by Country (2018-2023) & (Units)
Table 114. South America Aminoglycoside Drug Sales Quantity by Country (2024-2029) & (Units)
Table 115. South America Aminoglycoside Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 116. South America Aminoglycoside Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 117. Middle East & Africa Aminoglycoside Drug Sales Quantity by Type (2018-2023) & (Units)
Table 118. Middle East & Africa Aminoglycoside Drug Sales Quantity by Type (2024-2029) & (Units)
Table 119. Middle East & Africa Aminoglycoside Drug Sales Quantity by Application (2018-2023) & (Units)
Table 120. Middle East & Africa Aminoglycoside Drug Sales Quantity by Application (2024-2029) & (Units)
Table 121. Middle East & Africa Aminoglycoside Drug Sales Quantity by Region (2018-2023) & (Units)
Table 122. Middle East & Africa Aminoglycoside Drug Sales Quantity by Region (2024-2029) & (Units)
Table 123. Middle East & Africa Aminoglycoside Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 124. Middle East & Africa Aminoglycoside Drug Consumption Value by Region (2024-2029) & (USD Million)
Table 125. Aminoglycoside Drug Raw Material
Table 126. Key Manufacturers of Aminoglycoside Drug Raw Materials
Table 127. Aminoglycoside Drug Typical Distributors
Table 128. Aminoglycoside Drug Typical Customers
LIST OF FIGURES
Figure 1. Aminoglycoside Drug Picture
Figure 2. Global Aminoglycoside Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Aminoglycoside Drug Consumption Value Market Share by Type in 2022
Figure 4. Neomycin Examples
Figure 5. Tobramycin Examples
Figure 6. Gentamicin Examples
Figure 7. Amikacin Examples
Figure 8. Etimicin Examples
Figure 9. Others Examples
Figure 10. Global Aminoglycoside Drug Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 11. Global Aminoglycoside Drug Consumption Value Market Share by Application in 2022
Figure 12. Hospital Examples
Figure 13. Retail Pharmacy Examples
Figure 14. Others Examples
Figure 15. Global Aminoglycoside Drug Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 16. Global Aminoglycoside Drug Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 17. Global Aminoglycoside Drug Sales Quantity (2018-2029) & (Units)
Figure 18. Global Aminoglycoside Drug Average Price (2018-2029) & (US$/Unit)
Figure 19. Global Aminoglycoside Drug Sales Quantity Market Share by Manufacturer in 2022
Figure 20. Global Aminoglycoside Drug Consumption Value Market Share by Manufacturer in 2022
Figure 21. Producer Shipments of Aminoglycoside Drug by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 22. Top 3 Aminoglycoside Drug Manufacturer (Consumption Value) Market Share in 2022
Figure 23. Top 6 Aminoglycoside Drug Manufacturer (Consumption Value) Market Share in 2022
Figure 24. Global Aminoglycoside Drug Sales Quantity Market Share by Region (2018-2029)
Figure 25. Global Aminoglycoside Drug Consumption Value Market Share by Region (2018-2029)
Figure 26. North America Aminoglycoside Drug Consumption Value (2018-2029) & (USD Million)
Figure 27. Europe Aminoglycoside Drug Consumption Value (2018-2029) & (USD Million)
Figure 28. Asia-Pacific Aminoglycoside Drug Consumption Value (2018-2029) & (USD Million)
Figure 29. South America Aminoglycoside Drug Consumption Value (2018-2029) & (USD Million)
Figure 30. Middle East & Africa Aminoglycoside Drug Consumption Value (2018-2029) & (USD Million)
Figure 31. Global Aminoglycoside Drug Sales Quantity Market Share by Type (2018-2029)
Figure 32. Global Aminoglycoside Drug Consumption Value Market Share by Type (2018-2029)
Figure 33. Global Aminoglycoside Drug Average Price by Type (2018-2029) & (US$/Unit)
Figure 34. Global Aminoglycoside Drug Sales Quantity Market Share by Application (2018-2029)
Figure 35. Global Aminoglycoside Drug Consumption Value Market Share by Application (2018-2029)
Figure 36. Global Aminoglycoside Drug Average Price by Application (2018-2029) & (US$/Unit)
Figure 37. North America Aminoglycoside Drug Sales Quantity Market Share by Type (2018-2029)
Figure 38. North America Aminoglycoside Drug Sales Quantity Market Share by Application (2018-2029)
Figure 39. North America Aminoglycoside Drug Sales Quantity Market Share by Country (2018-2029)
Figure 40. North America Aminoglycoside Drug Consumption Value Market Share by Country (2018-2029)
Figure 41. United States Aminoglycoside Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Canada Aminoglycoside Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 43. Mexico Aminoglycoside Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. Europe Aminoglycoside Drug Sales Quantity Market Share by Type (2018-2029)
Figure 45. Europe Aminoglycoside Drug Sales Quantity Market Share by Application (2018-2029)
Figure 46. Europe Aminoglycoside Drug Sales Quantity Market Share by Country (2018-2029)
Figure 47. Europe Aminoglycoside Drug Consumption Value Market Share by Country (2018-2029)
Figure 48. Germany Aminoglycoside Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. France Aminoglycoside Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. United Kingdom Aminoglycoside Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Russia Aminoglycoside Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 52. Italy Aminoglycoside Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Asia-Pacific Aminoglycoside Drug Sales Quantity Market Share by Type (2018-2029)
Figure 54. Asia-Pacific Aminoglycoside Drug Sales Quantity Market Share by Application (2018-2029)
Figure 55. Asia-Pacific Aminoglycoside Drug Sales Quantity Market Share by Region (2018-2029)
Figure 56. Asia-Pacific Aminoglycoside Drug Consumption Value Market Share by Region (2018-2029)
Figure 57. China Aminoglycoside Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Japan Aminoglycoside Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Korea Aminoglycoside Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. India Aminoglycoside Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. Southeast Asia Aminoglycoside Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 62. Australia Aminoglycoside Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. South America Aminoglycoside Drug Sales Quantity Market Share by Type (2018-2029)
Figure 64. South America Aminoglycoside Drug Sales Quantity Market Share by Application (2018-2029)
Figure 65. South America Aminoglycoside Drug Sales Quantity Market Share by Country (2018-2029)
Figure 66. South America Aminoglycoside Drug Consumption Value Market Share by Country (2018-2029)
Figure 67. Brazil Aminoglycoside Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 68. Argentina Aminoglycoside Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Middle East & Africa Aminoglycoside Drug Sales Quantity Market Share by Type (2018-2029)
Figure 70. Middle East & Africa Aminoglycoside Drug Sales Quantity Market Share by Application (2018-2029)
Figure 71. Middle East & Africa Aminoglycoside Drug Sales Quantity Market Share by Region (2018-2029)
Figure 72. Middle East & Africa Aminoglycoside Drug Consumption Value Market Share by Region (2018-2029)
Figure 73. Turkey Aminoglycoside Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Egypt Aminoglycoside Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. Saudi Arabia Aminoglycoside Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 76. South Africa Aminoglycoside Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 77. Aminoglycoside Drug Market Drivers
Figure 78. Aminoglycoside Drug Market Restraints
Figure 79. Aminoglycoside Drug Market Trends
Figure 80. Porters Five Forces Analysis
Figure 81. Manufacturing Cost Structure Analysis of Aminoglycoside Drug in 2022
Figure 82. Manufacturing Process Analysis of Aminoglycoside Drug
Figure 83. Aminoglycoside Drug Industrial Chain
Figure 84. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 85. Direct Channel Pros & Cons
Figure 86. Indirect Channel Pros & Cons
Figure 87. Methodology
Figure 88. Research Process and Data Source
Figure 1. Aminoglycoside Drug Picture
Figure 2. Global Aminoglycoside Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Aminoglycoside Drug Consumption Value Market Share by Type in 2022
Figure 4. Neomycin Examples
Figure 5. Tobramycin Examples
Figure 6. Gentamicin Examples
Figure 7. Amikacin Examples
Figure 8. Etimicin Examples
Figure 9. Others Examples
Figure 10. Global Aminoglycoside Drug Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 11. Global Aminoglycoside Drug Consumption Value Market Share by Application in 2022
Figure 12. Hospital Examples
Figure 13. Retail Pharmacy Examples
Figure 14. Others Examples
Figure 15. Global Aminoglycoside Drug Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 16. Global Aminoglycoside Drug Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 17. Global Aminoglycoside Drug Sales Quantity (2018-2029) & (Units)
Figure 18. Global Aminoglycoside Drug Average Price (2018-2029) & (US$/Unit)
Figure 19. Global Aminoglycoside Drug Sales Quantity Market Share by Manufacturer in 2022
Figure 20. Global Aminoglycoside Drug Consumption Value Market Share by Manufacturer in 2022
Figure 21. Producer Shipments of Aminoglycoside Drug by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 22. Top 3 Aminoglycoside Drug Manufacturer (Consumption Value) Market Share in 2022
Figure 23. Top 6 Aminoglycoside Drug Manufacturer (Consumption Value) Market Share in 2022
Figure 24. Global Aminoglycoside Drug Sales Quantity Market Share by Region (2018-2029)
Figure 25. Global Aminoglycoside Drug Consumption Value Market Share by Region (2018-2029)
Figure 26. North America Aminoglycoside Drug Consumption Value (2018-2029) & (USD Million)
Figure 27. Europe Aminoglycoside Drug Consumption Value (2018-2029) & (USD Million)
Figure 28. Asia-Pacific Aminoglycoside Drug Consumption Value (2018-2029) & (USD Million)
Figure 29. South America Aminoglycoside Drug Consumption Value (2018-2029) & (USD Million)
Figure 30. Middle East & Africa Aminoglycoside Drug Consumption Value (2018-2029) & (USD Million)
Figure 31. Global Aminoglycoside Drug Sales Quantity Market Share by Type (2018-2029)
Figure 32. Global Aminoglycoside Drug Consumption Value Market Share by Type (2018-2029)
Figure 33. Global Aminoglycoside Drug Average Price by Type (2018-2029) & (US$/Unit)
Figure 34. Global Aminoglycoside Drug Sales Quantity Market Share by Application (2018-2029)
Figure 35. Global Aminoglycoside Drug Consumption Value Market Share by Application (2018-2029)
Figure 36. Global Aminoglycoside Drug Average Price by Application (2018-2029) & (US$/Unit)
Figure 37. North America Aminoglycoside Drug Sales Quantity Market Share by Type (2018-2029)
Figure 38. North America Aminoglycoside Drug Sales Quantity Market Share by Application (2018-2029)
Figure 39. North America Aminoglycoside Drug Sales Quantity Market Share by Country (2018-2029)
Figure 40. North America Aminoglycoside Drug Consumption Value Market Share by Country (2018-2029)
Figure 41. United States Aminoglycoside Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Canada Aminoglycoside Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 43. Mexico Aminoglycoside Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. Europe Aminoglycoside Drug Sales Quantity Market Share by Type (2018-2029)
Figure 45. Europe Aminoglycoside Drug Sales Quantity Market Share by Application (2018-2029)
Figure 46. Europe Aminoglycoside Drug Sales Quantity Market Share by Country (2018-2029)
Figure 47. Europe Aminoglycoside Drug Consumption Value Market Share by Country (2018-2029)
Figure 48. Germany Aminoglycoside Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. France Aminoglycoside Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. United Kingdom Aminoglycoside Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Russia Aminoglycoside Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 52. Italy Aminoglycoside Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Asia-Pacific Aminoglycoside Drug Sales Quantity Market Share by Type (2018-2029)
Figure 54. Asia-Pacific Aminoglycoside Drug Sales Quantity Market Share by Application (2018-2029)
Figure 55. Asia-Pacific Aminoglycoside Drug Sales Quantity Market Share by Region (2018-2029)
Figure 56. Asia-Pacific Aminoglycoside Drug Consumption Value Market Share by Region (2018-2029)
Figure 57. China Aminoglycoside Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Japan Aminoglycoside Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Korea Aminoglycoside Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. India Aminoglycoside Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. Southeast Asia Aminoglycoside Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 62. Australia Aminoglycoside Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. South America Aminoglycoside Drug Sales Quantity Market Share by Type (2018-2029)
Figure 64. South America Aminoglycoside Drug Sales Quantity Market Share by Application (2018-2029)
Figure 65. South America Aminoglycoside Drug Sales Quantity Market Share by Country (2018-2029)
Figure 66. South America Aminoglycoside Drug Consumption Value Market Share by Country (2018-2029)
Figure 67. Brazil Aminoglycoside Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 68. Argentina Aminoglycoside Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Middle East & Africa Aminoglycoside Drug Sales Quantity Market Share by Type (2018-2029)
Figure 70. Middle East & Africa Aminoglycoside Drug Sales Quantity Market Share by Application (2018-2029)
Figure 71. Middle East & Africa Aminoglycoside Drug Sales Quantity Market Share by Region (2018-2029)
Figure 72. Middle East & Africa Aminoglycoside Drug Consumption Value Market Share by Region (2018-2029)
Figure 73. Turkey Aminoglycoside Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Egypt Aminoglycoside Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. Saudi Arabia Aminoglycoside Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 76. South Africa Aminoglycoside Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 77. Aminoglycoside Drug Market Drivers
Figure 78. Aminoglycoside Drug Market Restraints
Figure 79. Aminoglycoside Drug Market Trends
Figure 80. Porters Five Forces Analysis
Figure 81. Manufacturing Cost Structure Analysis of Aminoglycoside Drug in 2022
Figure 82. Manufacturing Process Analysis of Aminoglycoside Drug
Figure 83. Aminoglycoside Drug Industrial Chain
Figure 84. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 85. Direct Channel Pros & Cons
Figure 86. Indirect Channel Pros & Cons
Figure 87. Methodology
Figure 88. Research Process and Data Source
